Trending at Lumira Ventures

G1 Therapeutics

jacki jenuth Current

G1 Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of novel small-molecule therapies to address significant unmet needs in oncology.


Alyssia Watkin Current

GenEp is a biotechnology company developing therapies that address unmet needs in patients with epilepsy.


Jennifer Schram Current

HistoSonics is a private medical device company whose mission is to redefine cancer treatment with a non-invasive, highly precise, cost-effective method of tumor destruction call Robotically Assisted Sonic Therapy (RAST™), based on the science of histotripsy.


Abi Kumar Current

IMV is a clinical stage company developing a suite of immunotherapeutics for the treatment of solid tumors and infectious diseases.

Iterion Therapeutics

admin Current

Iterion Therapeutics is developing novel cancer therapeutics targeting nuclear β-catenin, a historically “undruggable” oncology target implicated in cell proliferation.

KalGene Pharmaceuticals

jacki jenuth Current

KalGene Pharmaceuticals is a pre-clinical stage company focussed on the development of precision medicine therapeutics to slow the progression of Alzheimer’s disease.

KisoJi Biotechnology

jacki jenuth Current

KisoJi Biotechnology is an early stage biotechnology company engaged in the development of antibodies for the treatment of various cancers.

LAVA Medtech Acquisition Corp

Alyssia Watkin Current

LAVA Medtech Acquisition Corp. is a newly incorporated blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses.

LQT Therapeutics

Alyssia Watkin Current

LQT Therapeutics is developing therapies for genetic heart diseases pioneering a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

Medexus Pharmaceuticals

Jennifer Schram Current

Medexus Pharmaceuticals is a leading specialty pharmaceutical company with a strong North American commercial platform. Medexus is focused on the therapeutic areas of auto-immune disease and pediatrics.

Notch Therapeutics

Jennifer Schram Current

Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.


Alyssia Watkin Current

OncoMyx utilizes the Myxoma virus as both an oncolytic virus and a vehicle to deliver immunomodulatory proteins to treat a variety of both solid and liquid tumors to achieve the greatest therapeutic benefit for cancer patients.


jacki jenuth Current

Opsens is a fiber optic sensors manufacturer offering solutions for interventional cardiology Fractional Flow Reserve (FFR) as well as solutions for oil and gas industrial applications.


jacki jenuth Current

Based in Montreal, OsteoQC is developing new drug candidates for the treatment of bone-related diseases.

Satsuma Pharmaceuticals

Jennifer Schram Current

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing STS101 as an important and differentiated therapeutic option for the acute treatment of migraine.